Venetoclax
M21-569
Approved small_molecule active
Quick answer
Venetoclax for Acute Myeloid Leukemia (AML) is a Approved program (small_molecule) at AbbVie with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AbbVie
- Indication
- Acute Myeloid Leukemia (AML)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active